Theranos Whistleblower Says Nathan Fielder’s Elizabeth Holmes Documentary Got Some Things Wrong

**Whistleblower Tyler Shultz Shares Insight on New Elizabeth Holmes Documentary**

Tyler Shultz, a pivotal whistleblower in the Theranos scandal, has provided his perspective on the recent documentary ‘You Can See Everything,’ which focuses on the company’s founder, Elizabeth Holmes. Speaking to CBS Mornings, Shultz described a significant transformation he observed in Holmes compared to the confident persona he initially encountered.

Shultz characterised Holmes as a commanding presence when he first met her, recalling her ability “to completely command a room,” regardless of the high-profile individuals such as secretaries of state and military generals present in those meetings. However, he noted that the Holmes depicted in the documentary appeared markedly different, describing her as “unrecognisable” and “broken.” This stark contrast highlights her decline from a charismatic leader to a figure surrounded by controversy and legal challenges.

Holmes’ declaration in the film that she never lied has been met with scepticism from Shultz, who firmly asserted that this claim is, in itself, a deception. He referred to the extensive falsehoods that Holmes perpetuated, mentioning allegations by the Securities and Exchange Commission that she misled investors about Theranos’ financial status. She claimed that the company was generating annual revenue of $100 million, while the actual figure was a mere $100,000. Shultz emphasised that she consistently withheld audited financial statements from potential investors, contributing to the web of deceit surrounding Theranos.

Shultz’s journey with Theranos began in 2013 when he accepted an internship at the company. This opportunity arose after his grandfather, former Secretary of State George Shultz, joined the board of directors. Following an encounter with Holmes at a family gathering, Shultz applied for the role, eventually moving into a full-time position as a research engineer. It wasn’t long before he began questioning the validity of the company’s blood-testing technology.

After raising his concerns with Holmes, Shultz faced backlash from her partner and Theranos’ Chief Operating Officer, Sunny Balwani. In what Shultz described as a hostile email response, Balwani’s attack prompted Shultz to resign in April 2014. Undeterred, he took the courageous step of alerting regulators about the malfunctioning technology, playing a crucial role in the 2015 Wall Street Journal exposé that ultimately led to increased scrutiny of both Holmes and her company.

The costs of speaking out against Theranos were substantial for Shultz. He has previously detailed the retaliatory tactics employed by the company in an attempt to silence him. Despite this, he expressed a degree of sympathy for Holmes, especially in light of the personal consequences she faces. In an emotional moment during the interview, Shultz commented on the distressing sight of Holmes being separated from her children as she prepares for prison time. This moment illuminated the human aspect of the scandal, reflecting how the consequences of corporate deception often extend beyond the boardroom.

Though he recognises the pain caused by her situation, Shultz remains critical of Holmes’ intentions in presenting her story through the documentary. He believes that the overarching aim was to evoke sympathy from the audience. “I think that was the goal that Elizabeth had, was for you to come away from the movie with you having sympathy for her,” he remarked, complicating the narrative surrounding her legal battles. He acknowledged the difficulty in deflecting sympathy during the viewing experience, yet maintained that awareness of her manipulative tactics is essential.

In closing, Tyler Shultz’s reflections on both the documentary and his experiences with Theranos encapsulate the complexity of the Theranos saga. As the world continues to grapple with the fallout from one of the most notorious corporate frauds in recent history, the diverging perspectives on Elizabeth Holmes serve as a reminder of the intricate interplay between ambition, ethics, and accountability in the business world. The examination of this case extends beyond mere accountability; it prompts broader questions about the culture of Silicon Valley and the consequences of prioritising innovation over integrity.